The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment

HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nikki and LEYLAND, Rebecca (2020). The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment. Frontiers in Immunology, 11, p. 568931.

[img]
Preview
PDF
Leyland-ExtrinsicIntrinsicRoles(VoR).pdf - Published Version
Creative Commons Attribution.

Download (3MB) | Preview
Official URL: https://www.frontiersin.org/articles/10.3389/fimmu...
Open Access URL: https://www.frontiersin.org/articles/10.3389/fimmu... (Published version)
Link to published version:: https://doi.org/10.3389/fimmu.2020.568931

Abstract

Programmed death-ligand 1 (PD-L1) is an immune checkpoint inhibitor that binds to its receptor PD-1 expressed by T cells and other immune cells to regulate immune responses; ultimately preventing exacerbated activation and autoimmunity. Many tumors exploit this mechanism by overexpressing PD-L1 which often correlates with poor prognosis. Some tumors have also recently been shown to express PD-1. On tumors, PD-L1 binding to PD-1 on immune cells promotes immune evasion and tumor progression, primarily by inhibition of cytotoxic T lymphocyte effector function. PD-1/PD-L1-targeted therapy has revolutionized the cancer therapy landscape and has become the first-line treatment for some cancers, due to their ability to promote durable anti-tumor immune responses in select patients with advanced cancers. Despite this clinical success, some patients have shown to be unresponsive, hyperprogressive or develop resistance to PD-1/PD-L1-targeted therapy. The exact mechanisms for this are still unclear. This review will discuss the current status of PD-1/PD-L1-targeted therapy, oncogenic expression of PD-L1, the new and emerging tumor-intrinisic roles of PD-L1 and its receptor PD-1 and how they may contribute to tumor progression and immunotherapy responses as shown in different oncology models.

Item Type: Article
Uncontrolled Keywords: 1107 Immunology; 1108 Medical Microbiology
Identification Number: https://doi.org/10.3389/fimmu.2020.568931
Page Range: p. 568931
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 21 Oct 2020 14:10
Last Modified: 17 Mar 2021 21:46
URI: https://shura.shu.ac.uk/id/eprint/27486

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics